Merck KGaA / MilliporeSigma (CDMO) vs ReciBioPharm: CDMO Comparison
Side-by-side comparison of Merck KGaA / MilliporeSigma (CDMO) and ReciBioPharm on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Merck KGaA / MilliporeSigma (CDMO) has FDA inspections on record (2); ReciBioPharm does not yet appear in the FDA inspection database.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates; ReciBioPharm does not appear in EudraGMDP.
- ReciBioPharm maintains 3 MHRA / UK GMP certificates; Merck KGaA / MilliporeSigma (CDMO) does not.
- Merck KGaA / MilliporeSigma (CDMO) appears as a manufacturing partner on more matched clinical programs (22 vs 0) — a broader sponsor book.
On a 13-modality CDMO landscape, both Merck KGaA / MilliporeSigma (CDMO) and ReciBioPharm qualify as mRNA/LNP manufacturers; ReciBioPharm carries the higher composite Signal Score for mRNA/LNP programs in this comparison.
What to evaluate for mRNA/LNP programs
Both Merck KGaA / MilliporeSigma (CDMO) and ReciBioPharm qualify as mRNA/LNP CDMOs. When choosing between them for mRNA/LNP programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
IVT mRNA synthesis
Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost.
LNP formulation
LNP encapsulation via microfluidics determines potency and tolerability. Confirm lipid sourcing, formulation freedom-to-operate, and particle-size control.
Plasmid / starting material
mRNA needs a DNA template. Check whether the CDMO supplies GMP plasmid in-house or coordinates a plasmid CDMO — it affects timelines.
Cold chain & stability
mRNA-LNP products are temperature-sensitive. Evaluate frozen storage, fill-finish, and the stability program.
Frequently asked: Merck KGaA / MilliporeSigma (CDMO) vs ReciBioPharm
Which has the stronger FDA inspection record, Merck KGaA / MilliporeSigma (CDMO) or ReciBioPharm?
Both Merck KGaA / MilliporeSigma (CDMO) and ReciBioPharm maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Merck KGaA / MilliporeSigma (CDMO) has 2 FDA inspections on record; ReciBioPharm has 0.
How do Merck KGaA / MilliporeSigma (CDMO) and ReciBioPharm compare on European GMP coverage?
Merck KGaA / MilliporeSigma (CDMO) holds 2 active EMA GMP certificates and 0 MHRA / UK certificates. ReciBioPharm holds 0 active EMA GMP certificates and 3 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — Merck KGaA / MilliporeSigma (CDMO) or ReciBioPharm?
Merck KGaA / MilliporeSigma (CDMO) is matched to 22 ClinicalTrials.gov records as a manufacturing partner; ReciBioPharm is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for mRNA/LNP manufacturing — Merck KGaA / MilliporeSigma (CDMO) or ReciBioPharm?
Both Merck KGaA / MilliporeSigma (CDMO) and ReciBioPharm are tagged as mRNA/LNP CDMOs in our directory, so both are credible options for mRNA/LNP programs. The most important differentiator for mRNA/LNP selection is typically ivt mrna synthesis: Assess in-vitro transcription scale, capping strategy (co-transcriptional vs enzymatic), and template sourcing. These drive yield, purity, and cost. Review each CDMO's profile and inspection record before shortlisting.
What does the Signal Score gap mean in practice?
Merck KGaA / MilliporeSigma (CDMO) carries a Signal Score of 82/100 and ReciBioPharm carries 88/100 — a small lead for ReciBioPharm. The Signal Score combines quality (FDA inspections + EMA/MHRA GMP), operational performance, financial stability, and capacity intelligence. CDMOs cannot pay to influence their score.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →